This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (13)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Jonathan Abrams, MD

JAMA. 1985;254(21):3070-3074.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE USE of vasodilators as adjunctive therapy for congestive heart failure was first popularized over ten years ago by the work of Parmley, Chatterjee, Cohn, and Franciosa, although occasional clinical investigative reports using vasodilators date back to the 1950s and even earlier. Physicians have had considerable experience with vasodilators, yet important questions remain unanswered regarding the ultimate role of this therapeutic approach to the failing heart. This review will focus on the present status of the currently available vasodilators (nitrates, hydralazine hydrochloride, prazosin hydrochloride, and captopril) in the management of chronic congestive heart failure.

THE CONCEPT OF VASODILATOR THERAPY Afterload or Impedance Reduction

Afterload, a term derived from isolated cardiac muscle experiments, is best defined as the forces opposing left ventricular fiber shortening during ejection. Impedance, a term preferred by many investigators, is the instantaneous resistance to flow to the contracting left ventricle and is equivalent to instantaneous left ventricular . . . [Full Text PDF of this Article]

Author Affiliations
From the Department of Medicine, The University of New Mexico School of Medicine, Albuquerque.

Footnotes
This article is one of a series sponsored by the American Heart Association.

Reprint requests to the Department of Medicine, The University of New Mexico School of Medicine, 2211 Lomas Blvd NE, Albuquerque, NM 87131 (Dr Abrams).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?